Skip to main content
Livermore
Livermore
ZHEN

US Bancorp

SEC CIK
0000036104
Latest filing
Aug 12, 2026

TGTX holding history

TG Therapeutics, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TGTX overviewAll 13F holders of TGTXFull Q2 2026 holdings

Shares (Q2 2026)
2,906
Value
$159.7K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of TGTX by US Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,906$159.7K<0.1%+109+3.9%AddedHolders
Q1 20262,797$92.9K<0.1%+204+7.9%AddedHolders
Q4 20252,593$77.3K<0.1%−37−1.4%ReducedHolders
Q3 20252,630$95.0K<0.1%−518−16.5%ReducedHolders
Q2 20253,148$113.3K<0.1%−685−17.9%ReducedHolders
Q1 20253,833$151.1K<0.1%+15+0.4%AddedHolders
Q4 20243,818$114.9K<0.1%−986−20.5%ReducedHolders
Q3 20244,804$112.4K<0.1%−24−0.5%ReducedHolders
Q2 20244,828$85.9K<0.1%−1,402−22.5%ReducedHolders
Q1 20246,230$94.8K<0.1%+1,143+22.5%AddedHolders
Q4 20235,087$86.9K<0.1%+4,650+1,064.1%AddedHolders
Q3 2023437$3.65K<0.1%−9,276−95.5%ReducedHolders
Q2 20239,713$241.3K<0.1%+7,363+313.3%AddedHolders
Q1 20232,350$35.3K<0.1%−20,348−89.6%ReducedHolders
Q4 202222,698$268.5K<0.1%+19,432+595.0%AddedHolders
Q3 20223,266$19.0K<0.1%+1,978+153.6%AddedHolders
Q2 20221,288$5.00K<0.1%−170−11.7%ReducedHolders
Q1 20221,458$14.0K<0.1%+1,074+279.7%AddedHolders
Q4 2021384$7.00K<0.1%−38−9.0%ReducedHolders
Q3 2021422$14.0K<0.1%−13,130−96.9%ReducedHolders
Q2 202113,552$525.0K<0.1%+88+0.7%AddedHolders
Q1 202113,464$649.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.